Case report: olaparib as an experimental therapy in a brca2-mutated patient with metastatic ovarian adenocarcinoma that originated from liver cancer

HIGHLIGHTS

• who: Caixia Li from the Fudan University, China have published the article: Case report: Olaparib as an experimental therapy in a BRCA2-mutated patient with metastatic ovarian adenocarcinoma that originated from liver cancer, in the Journal: (JOURNAL) of 18/08/2020
• what: The authors report the case of a 66-year-old woman with rare ovarian and omentum metastases that originated from liver cancer.
• how: In the case of the patient the authors prepared genetic test with the patient`s consent after the operation and the results showed that the patient carried mutations . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.